Hives case reported in Toyama as possible side effect of COVID-19 vaccination

COVID-19 vaccination A medical worker fills a syringe with a dose of the Pfizer-BioNTech COVID-19 vaccine as the country launches its inoculation campaign at the Tokyo Medical Center in Tokyo on February 17, 2021. AFP/Behrouz MEHRI

The Japanese government said Saturday it has received a report of a potential side effect from coronavirus vaccination, hives, in the wake of the vaccination rollout in the country earlier this week.

The case occurred at a hospital in Toyama Prefecture on Friday, the prime minister’s office said in a tweet.

Toyama Rosai Hospital said the hives occurred in a person after inoculation but the symptoms quickly disappeared. The hospital has declined to reveal details about the person.

The hospital, along with another one in the prefecture, began administering the vaccine on health care workers from Friday. On that day, 48 people received vaccinations at the hospital.

Japan launched its vaccination effort on Wednesday, initially for 40,000 medical workers at 100 hospitals across the country. There have been no reports of serious side effects of the vaccine developed by U.S. drugmaker Pfizer Inc. and Germany’s BioNTech SE.

If a person dies due to side effects following a coronavirus vaccination, the government will pay 44.2 million yen in compensation to the bereaved family, according to the health ministry.

Of the initial group of 40,000 health workers, 20,000 are taking part in a study to track potential side effects caused by the vaccine. They are asked to keep daily records for seven weeks after taking the first of two shots. The shots will be administered three weeks apart.


Please enter your comment!
Please enter your name here